BUJ-33434-06109 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-17
Dose 1 — Pfizer-BioNTech
2020-12-20
Registered in v-safe
2020-12-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-24
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2020-12-31
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-06
Dose 2 — Pfizer-BioNTech
2021-01-06
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches

Adult check-in
2021-01-07
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-08
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-11
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-13
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-20
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-01-27
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-03
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-10
Survey response — day 35, dose 2
MedDRA: Erythema nodosum, Pre-existing disease, Pregnancy — Feeling: Good

Free text: Erythema nodosum. I have a history of one prior episode, and I remain pregnant at this time (28 weeks).

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-17
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-07
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-06
Survey response — 12 months, dose 2
MedDRA: Vulval ulceration — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Transient labial ulcers developed 5 days after receiving Pfizer booster shot. Tested for HSV and was negative. No alternative cause identified. Self-resolved.

MedDRA releases: 2024-11 · check-in free text available
2022-01-06
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-10
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-17	Pfizer-BioNTech
2	2021-01-06	Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 4 — day 35, dose 2

2021-02-10

Symptoms: Erythema nodosum. I have a history of one prior episode, and I remain pregnant at this time (28 weeks).

Release 10 — 12 months, dose 2

2022-01-06

Symptoms: Transient labial ulcers developed 5 days after receiving Pfizer booster shot. Tested for HSV and was negative. No alternative cause identified. Self-resolved.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Erythema nodosum	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SD	Pregnancy	✓	✓	✓
SD	Vulval ulceration	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release